Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Caution evidenceCoverage 4/5 core metricsLatest reported annual revenue changed -5.7% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -5.7% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin compressed
Operating margin changed -17.2 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was negative
Latest reported free cash flow was -$36M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- 2 filing risk checks flagged
Flagged areas: Solvency & liquidity, Dilution.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
- Dilution
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Cell Engineering Technology Segment$33Mshare n/a-14.5% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Product$18.7Mshare n/a-11.4% yoy
- License$12.4Mshare n/a-24.6% yoy
- Assay And Other Service Revenue$1.97Mshare n/ano prior
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$21.1Mshare n/a-18.2% yoy
- Outside the United States$11.9Mshare n/a-7.1% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Cell Engineering Technology Segment$9.65M100.0%-7.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,058 US-listed filers · 320 in Industrials| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $21M | 15thof 3,301 bottom third | 11thof 305 bottom third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -5.7% | 17thof 3,137 bottom third | 19thof 294 bottom third |
Gross margin gross profit ÷ revenue | 127.9% | 99thof 1,603 top third | 100thof 167 top third |
Operating margin operating income ÷ revenue | -247.6% | 11thof 2,819 bottom third | 9thof 280 bottom third |
Net margin net income ÷ revenue | -213.0% | 11thof 3,263 bottom third | 9thof 299 bottom third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -172.6% | 10thof 2,679 bottom third | 8thof 276 bottom third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -26.0% | 26thof 3,577 bottom third | 19thof 281 bottom third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 44.0% | 10thof 2,895 bottom third | 7thof 266 bottom third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 61 days | 35thof 2,398 middle third | 31stof 238 bottom third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
Not available for MXCT yet: Earnings-quality fields arrive with this issuer's next re-crawl (sec_screen_v6)..
Point-in-time ledger
Not available for MXCT yet: The point-in-time ledger arrives with this issuer's next re-crawl (sec_screen_v6)..
Notes by disclosure type
Not available for MXCT yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.